Literature DB >> 11877428

Importance of C1B domain for lipid messenger-induced targeting of protein kinase C.

Kaori Kashiwagi1, Yasuhito Shirai, Masamitsu Kuriyama, Norio Sakai, Naoaki Saito.   

Abstract

The molecular mechanisms by which arachidonic acid (AA) and ceramide elicit translocation of protein kinase C (PKC) were investigated. Ceramide translocated epsilonPKC from the cytoplasm to the Golgi complex, but with a mechanism distinct from that utilized by AA. Using fluorescence recovery after photobleaching, we showed that, upon treatment with AA, epsilonPKC was tightly associated with the Golgi complex; ceramide elicited an accumulation of epsilonPKC which was exchangeable with the cytoplasm. Stimulation with ceramide after AA converted the AA-induced Golgi complex staining to one elicited by ceramide alone; AA had no effect on the ceramide-stimulated localization. Using point mutants and deletions of epsilonPKC, we determined that the epsilonC1B domain was responsible for the ceramide- and AA-induced translocation. Switch chimeras, containing the C1B from epsilonPKC in the context of deltaPKC (delta(epsilonC1B)) and vice versa (epsilon(deltaC1B)), were generated and tested for their translocation in response to ceramide and AA. delta(epsilonC1B) translocated upon treatment with both ceramide and AA; epsilon(deltaC1B) responded only to ceramide. Thus, through the C1B domain, AA and ceramide induce different patterns of epsilonPKC translocation and the C1B domain defines the subtype specific sensitivity of PKCs to lipid second messengers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877428     DOI: 10.1074/jbc.M111761200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol.

Authors:  Arathi Raghunath; Mia Ling; Christer Larsson
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 2.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 3.  Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.

Authors:  Thomas H Beckham; Saeed Elojeimy; Joseph C Cheng; Lorianne S Turner; Stanley R Hoffman; James S Norris; Xiang Liu
Journal:  Expert Opin Ther Targets       Date:  2010-05       Impact factor: 6.902

Review 4.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 5.  Cellular membranes and lipid-binding domains as attractive targets for drug development.

Authors:  C G Sudhahar; R M Haney; Y Xue; R V Stahelin
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

6.  PKC-ε pseudosubstrate and catalytic activity are necessary for membrane delivery during IgG-mediated phagocytosis.

Authors:  Tiffany R Wood; Rachel Y Chow; Cheryl M Hanes; Xuexin Zhang; Kaori Kashiwagi; Yasuhito Shirai; Mohamed Trebak; Daniel J Loegering; Naoaki Saito; Michelle R Lennartz
Journal:  J Leukoc Biol       Date:  2013-05-13       Impact factor: 4.962

Review 7.  Exploring the link between ceramide and ionizing radiation.

Authors:  Massimo Aureli; Valentina Murdica; Nicoletta Loberto; Maura Samarani; Alessandro Prinetti; Rosaria Bassi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 8.  From lipid second messengers to molecular motors: microtubule-organizing center reorientation in T cells.

Authors:  Morgan Huse; Audrey Le Floc'h; Xin Liu
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 9.  Visualizing bioactive ceramides.

Authors:  Daniel Canals; Silvia Salamone; Yusuf A Hannun
Journal:  Chem Phys Lipids       Date:  2018-09-25       Impact factor: 3.329

10.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.